Hints and tips:
...Myers Squibb Q1, Capital One Q1, Caterpillar Q1, Comcast Q1, Dassault Systemes Q1, Delivery Hero Q1 trading update, Deutsche Bank Q1, Dow Q1, Drax Group AGM and trading update, Inchcape Q1, Intel Q1, London...
...Myers Squibb to acquire Mirati in up to $5.8bn deal (Reuters) German auto group Schaeffler swoops for Vitesco with €3bn bid (FT) Big banks sit out LBO rebound after being stung by earlier buyouts (FT)...
...From the pharmaceuticals sector, Bristol-Myers Squibb — which recently agreed to buy Celgene in one of the largest pharmaceutical deals in history — reports....
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
...The sale allows Bristol-Myers Squibb to push ahead with its mammoth $90bn takeover of Celgene....
...The two banks have landed on some of the biggest deals of the year, with JPMorgan advising on the $90bn tie-up between Bristol-Myers Squibb and Celgene and Goldman providing advice to Allergan on its $85bn...
...Bristol-Myers Squibb, a mammoth US drugmaker on the brink of completing a $90bn merger with Celgene — one of the largest in pharma history — is Starboard’s latest target....
...The Supreme Court in June ruled in Bristol-Myers Squibb v Superior Court that, in product liability and mass tort cases, plaintiffs can only sue companies in states where they purchase or use the product...
...Bristol Myers Squibb was a rare gainer, its shares lifting 1.7 per cent to $21.02 after the US Food and Drug Administration said analyses of its experimental diabetes drug showed it met the agency’s guidelines...
International Edition